The role of therapeutic plasma exchange using membrane plasma separation in the late onset myasthenic crisis: a case report | [Anaesthesia, Pain and Intensive Care • 2024]

Author(s):

1. Dedy Kurnia: Department of Anesthesiology and Intensive Care, Faculty of Medicine, Universitas Indonesia,Jakarta,Indonesia

2. Sidharta Kusuma Manggala: Department of Anesthesiology and Intensive Care, Faculty of Medicine, Universitas Indonesia,Jakarta,Indonesia

3. Vera Irawany: Department of Anesthesiology and Intensive Care, Fatmawati General Hospital,Jakarta,Indonesia

Abstract:

Myasthenia gravis (MG) is an autoimmune disease, in which antibodies bind to receptors in the neuromuscular junction (NMJ), causing muscle weakness. This disease is relatively challenging to diagnose due to its late onset and comorbidities. Several treatment options include therapeutic plasma exchange (TPE) with membrane plasma separation, that aims to remove large molecular-weight toxins such as pathogenic antibodies and lipoproteins. A 61year-old male patient was admitted to the ICU post-sternotomy due to mediastinal tumor resection. Extubation failed, so we decided to undergo a tracheostomy. The lung pathology result showed lymphocyte-predominant thymoma, and along with symptoms of chest weakness and ptosis, the patient was suspected for MG. Electromyography results confirmed the occurrence of functional lesions in post-synaptic NMJ consistent with MG. We assessed patient with myasthenic crisis (MC), then gave pyridostigmine 60 mg 6x/day, and planned for TPE using membrane plasma separation. Plasma exchange was done by 1.5 of blood volume. The patient developed sepsis pneumonia and was administered levofloxacin based on his culture results. Patient still had weakness. We reevaluated the drugs that might have exacerbated MG. Aztreonam in combination with co-trimoxazole was administered to combat Stenotrophomonas maltophilia pneumonia. The patient was eventually weaned from the ventilator and gradually recovered.

Page(s): 969-973

DOI: 10.35975/apic.v28i5.2557

Published: Journal: Anaesthesia, Pain and Intensive Care, Volume: 28, Issue: 5, Year: 2024

Keywords:

Therapeutic plasma exchange , TPE , Membrane Plasma Separation , Myasthenia Gravis Crisis

References:

[1] Mateos-Dávila A,Betbesé Roig AJ,Santos Rodríguez JA,GuixComellas EM .2023 .Change in prefilter pressure as a key determinant in the decision to return blood in continuous renal replacement therapy: An observational study. Nurs Crit Care, : .

[2] Alshehri SD,Al Sulaiman K,Aljuhani O,Al Harbi SA,Alalawi M,Alenazi AA .2022 .Therapeutic plasma exchange and supratherapeutic levels of unfractionated heparin in the management of critically ill patient with myasthenia gravis: A case report. Am J Case Rep, 23 : .

[3] Sheckley H,Malhotra K,Katyal N,Narula N,Govindarajan R. .2021 .Clinical experience with maintenance therapeutic plasma exchange in refractory generalized myasthenia gravis. J Clin Apher, 36(5) : 727-36.

[4] Sheikh S,Alvi U,Soliven B,Rezania K. .2021 .Drugs that induce or cause deterioration of myasthenia gravis: An update. J Clin Med, 10(7) : 1537.

[5] Emeraud C,Escaut L,Boucly A,Fortineau N,Bonnin RA,Naas T .2019 .Aztreonam plus clavulanate, tazobactam, or avibactam for treatment of infections caused by metallo-β-lactamaseproducing gram-negative bacteria. Antimicrob Agents Chemother, 63(5) : 19.

Citations

Downloads

Views